UAS
United Asset Strategies’s Thermo Fisher Scientific TMO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $10.6M | Sell |
26,211
-10,128
| -28% | -$4.11M | 0.91% | 39 |
|
2025
Q1 | $18.1M | Buy |
36,339
+9,070
| +33% | +$4.51M | 1.68% | 10 |
|
2024
Q4 | $14.2M | Buy |
27,269
+1,118
| +4% | +$582K | 1.3% | 22 |
|
2024
Q3 | $16.2M | Buy |
26,151
+950
| +4% | +$588K | 1.51% | 17 |
|
2024
Q2 | $13.9M | Buy |
25,201
+768
| +3% | +$425K | 1.38% | 23 |
|
2024
Q1 | $14.2M | Buy |
24,433
+1,150
| +5% | +$668K | 1.42% | 19 |
|
2023
Q4 | $12.4M | Buy |
23,283
+1,033
| +5% | +$548K | 1.39% | 22 |
|
2023
Q3 | $11.3M | Buy |
22,250
+287
| +1% | +$145K | 1.46% | 18 |
|
2023
Q2 | $11.5M | Buy |
21,963
+303
| +1% | +$158K | 1.43% | 19 |
|
2023
Q1 | $12.5M | Buy |
21,660
+220
| +1% | +$127K | 1.65% | 17 |
|
2022
Q4 | $11.8M | Buy |
21,440
+137
| +0.6% | +$75.4K | 1.65% | 17 |
|
2022
Q3 | $10.8M | Buy |
21,303
+53
| +0.2% | +$26.9K | 1.66% | 15 |
|
2022
Q2 | $11.5M | Buy |
21,250
+1,719
| +9% | +$934K | 1.68% | 18 |
|
2022
Q1 | $11.5M | Sell |
19,531
-1,643
| -8% | -$970K | 1.47% | 19 |
|
2021
Q4 | $14.1M | Sell |
21,174
-395
| -2% | -$264K | 1.68% | 16 |
|
2021
Q3 | $12.3M | Buy |
21,569
+282
| +1% | +$161K | 1.59% | 20 |
|
2021
Q2 | $10.7M | Buy |
21,287
+292
| +1% | +$147K | 1.43% | 25 |
|
2021
Q1 | $9.58M | Buy |
20,995
+2,221
| +12% | +$1.01M | 1.39% | 27 |
|
2020
Q4 | $8.74M | Buy |
18,774
+274
| +1% | +$128K | 1.37% | 25 |
|
2020
Q3 | $8.17M | Sell |
18,500
-568
| -3% | -$251K | 1.5% | 23 |
|
2020
Q2 | $6.91M | Buy |
19,068
+304
| +2% | +$110K | 1.36% | 23 |
|
2020
Q1 | $5.32M | Buy |
+18,764
| New | +$5.32M | 1.32% | 26 |
|